CRF: Circulating recombinant form; NNRTI: Non-nucleoside reverse-transcriptase inhibitor; NRTI: Nucleos(t)ide analog reverse-transcriptase inhibitor. Eight nucleos(t)ide analog reverse ...

Am J Health Syst Pharm. 2010;67(3):193-205. Significant pharmacokinetic interactions were observed when etravirine was used in combination with tipranavir-ritonavir, fosamprenavir-ritonavir, and ...

Sequence variations in human immunodeficiency virus (HIV)-1 reverse transcriptase (RT ... prolonged treatment with multiple nucleoside RT inhibitors. The occurrence of reading frame shifts ...

The four main classes, which most people are treated with, target one of three viral proteins which control HIV’s lifecycle: reverse transcriptase, integrase and protease. Historically, most people ...

The latest recommendations are presented for the treatment and prevention of HIV, including new antiretroviral therapies and long-acting injectable options.